Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/28/2854441/0/en/Eledon-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Operating-and-Financial-Results.html
https://www.globenewswire.com/news-release/2024/03/25/2852025/0/en/Eledon-Pharmaceuticals-Announces-12th-Participant-Enrolled-in-Phase-2-BESTOW-Trial-Evaluating-Tegoprubart-for-the-Prevention-of-Organ-Rejection.html
https://www.globenewswire.com/news-release/2024/03/21/2850358/0/en/Eledon-Pharmaceuticals-Announces-Use-of-Tegoprubart-in-First-ever-Transplant-of-Genetically-Modified-Kidney-from-a-Pig-to-a-Human.html
https://www.globenewswire.com//news-release/2024/02/14/2828721/0/en/Eledon-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/01/04/2804366/0/en/Eledon-Pharmaceuticals-Highlights-Recent-Business-Milestones-and-Provides-2024-Outlook.html
https://www.globenewswire.com//news-release/2023/12/04/2790532/0/en/Eledon-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2023/11/29/2788093/0/en/Eledon-Pharmaceuticals-to-Present-at-Noble-Capital-Markets-Emerging-Growth-Equity-Conference.html
https://www.globenewswire.com//news-release/2023/11/09/2777769/0/en/Eledon-Pharmaceuticals-Reports-Third-Quarter-2023-Operating-and-Financial-Results.html
https://www.globenewswire.com//news-release/2023/11/08/2776675/0/en/Eledon-Pharmaceuticals-to-Present-at-Jefferies-London-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/02/2772435/0/en/Eledon-Reports-Updated-Data-from-Ongoing-Phase-1b-Trial-Evaluating-Tegoprubart-for-Prevention-of-Rejection-in-Kidney-Transplantation.html